Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-Year results of a randomized clinical trial - VIP report no. 3

Ophthalmology

Volumn 110, Issue 4, 2003, Pages 667-673

  Blinder, Kevin J ^a   Blumenkranz, Mark S ^a   Bressler, Neil M ^a   Bressler, Susan B ^a   Donati, Guy ^a   Lewis, Hilel ^a   Lim, Jennifer I ^a   Menchini, Ugo ^a   Miller, Joan W ^a   Mones, Jordi M ^a   Potter, Michael J ^a   Pournaras, Constantin ^a   Reaves, Al ^a   Rosenfeld, Philip ^a   Schachat, Andrew P ^a   Schmidt Erfurth, Ursula ^a   Sickenberg, Michel ^a   Singerman, Lawrence J ^a   Slakter, Jason S ^a   Strong, H Andrew ^a   Virgili, Gianni ^a   Williams, George A ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOPIA; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0242500327     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01998-X     Document Type: Article

References (7)

1. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial - VIP Report 1. Ophthalmology 2001;108:841-52.
2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One year results of 2 randomized clinical trials - TAP Report 1, [published erratum appears in Arch Ophthalmol 2000;118:488]. Arch Ophthalmol 1999;117:1329-45.
3. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-57.
4. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy Report 2. Am J Ophthalmol 2001;131:541-60.
5. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol 2001;119:198-207.
6. Chow SC, Liu JP. Design and Analysis of Clinical Trials: Concepts and Methodologies, New York: John Wiley & Sons, 1998:331-3.
7. Chow SC, Liu JP. Design and Analysis of Clinical Trials: Concepts and Methodologies. New York: John Wiley & Sons, 1998:277-80, 286-90.